Kintor Pharma focuses on developing innovative small molecules and biologic drugs for dermatology and oncology with substantial unmet needs, especially androgen receptor-related diseases. Kintor Pharma's product pipeline consists of seven ongoing clinical products, including androgen receptor antagonists, AR-PROTAC, ALK-1 monoclonal antibody, Hedgehog/SMO inhibitor, mTOR inhibitor and PD-L1/TGF-β dual-targeting antiobdy. The company also has ongoing preclinical programs in ALK-1/VEGF dual-targeting antibody and c-Myc inhibitors. We are actively seeking partnerships for China and worldwide, welcome to contact us!

　　Tel：+86 512 6263 9916，+86 512 6263 9920

　　Email：BD@kintor.com.cn